Appropriate proteolytic targeting by SKP2 is essential for the fidelity of many key biological processes required for genome stability (e.g., cell cycle progression, signal transduction, and gene expression), and thus, it is not surprising that SKP2 overexpression is traditionally implicated in cancer pathogenesis [17,34,35]. Here, SKP2 is linked to cancer.